| Tuesday, March 11, 2008 Harvard University
Sherman Fairchild Lecture Hall, 7 Divinity Avenue, Cambridge This event is offered free of charge to the general public.
Advances in stem cell research have the potential to create life-saving treatments for debilitating diseases and injuries, many of which have been virtually impossible to treat with existing therapeutics. Researchers in diabetes, cardiovascular, nervous system and blood diseases are looking at options that involve stimulating existing stem cell populations, transplanting stem cells and coaxing targeted stem cells using chemical compounds. Which methods demonstrate promise and what are the key questions being addressed in the lab?
Join us as HSCI disease program heads gather to discuss the state of experiments being done in the laboratory to identify areas of progress and potential. In these 'key disease' areas, we will learn where the challenges lie and what the future may realistically hold. Introduction by Brock Reeve, HSCI Executive Director.
Panel
Gordon Weir, MD
HSCI Program Head, Diabetes
Joslin Diabetes Center
Kenneth Chien, MD, PhD
HSCI Program Head, Cardiovascular
MGH
Jeffrey Macklis, MD, D.HST
HSCI Program Head, Nervous System
MGH
David Scadden, MD
HSCI Co-Director, Blood and Cancer
MGH
Moderator
Kevin Eggan, PhD
HSCI Principal Faculty
Harvard University Light refreshments will be available. Use of public transportation is encouraged.
| 
